Interested in Subscribing to Our Newletters and Articles?
Income Growth Advisors’ MLP Accounts Significantly Outperform MLP Funds.
Income Growth Advisors’ MLP Separately Managed Accounts (SMAs) rose 22.09% for the trailing twelve months ended this past April. This performance declined with oil’s price
1 year 57.08%, 3 year 0.09%, 5 year 8.27%, 10 year 11.78% and 15.35% annualized since inception. Notable outperformance to S&P 500, AMZX and AMLP.
For the past twelve months, Income Growth Advisors’ MLP Separately Managed Accounts (SMAs) rose 57.08% on a size weighted basis even though they declined 1.53%
Latest MLP Report Published on Barron’s Online.
Read the full article by Amey Stone here: http://bit.ly/Tyson_Halsey_Barrons
1 year 76.66%, 3 year 1.66%, 5 year 8.26%, 10 year 12.43% and 15.54% annualized since inception. Notable outperformance to S&P 500, AMZX and AMLP.
Income Growth Advisors’ MLP Separately Managed Accounts (SMAs) lost 5.03% for February. For the past twelve months, our returns rose 76.66% on a size weighted
IGA MLPs up 4.4% in January and 79.05% for trailing twelve months after fees.
Income Growth Advisors, LLC MLP Separately Managed Account (SMA)’s rose 4.40% in January. For the trailing twelve months, we delivered strong performance with returns up
IGA MLP SMA performance up 12.49% for December. Full year 2016 49.94%, 3 yr. 3.35%, 5 yr. 11.20%, 10 yr. 13.45% since inception 15.79%
Income Growth Advisors, LLC MLP Separately Managed Account (SMA)’s rose 12.49% in December. For the full year, we delivered strong performance with returns up 49.94%
Trump Election Implications
There are three big ideas to consider in the wake of Donald Trump’s stunning election victory. The first is that we have a business man
IGA’s MLP performance beats benchmarks and ETFs up 5.35% for November, 33.30% year to date, 23.29% one year, -0.01% three year, 9.40% five year, 12.30% ten year, and 15.03% since inception.
We have commenced reporting our returns on a net of fee basis. Our maximum fee for MLP accounts is 1.65%. After backing this out from
Why there is a potentially highly rewarding opportunity in Trillium Therapeutics, Inc. TRIL
Several very smart biotechnology investors, doctors, and analysts turned my attention to Trillium Therapeutics, Inc (TRIL) this year. We initially started buying the stock in
Income Growth Advisors, LLC MLP SMAs have outperformed the AMLP 11.89% annually, since inception. Year to date IGA’s MLP SMAs rose 28.23% on a size weighted and 66.58% on an equal weighted basis, before management fee. See disclaimer in attached PDF.
Income Growth Advisors, LLC MLP Separately Managed Account (SMA) performance declined 2.80% in October, beating our MLP benchmark index, the Alerian (AMZX), which declined 4.45%.
The CFA Code of Ethics
Members of CFA Institute (including CFA charterholders) and candidates for the CFA designation (“Members and Candidates”) must: • Act with integrity, competence, diligence, respect and
Income Growth Advisors, LLC MLP year to date returns are up 26.73% and 61.28% on a size and equal weighted basis, respectively.
Income Growth Advisors, LLC MLP strategy’s market value declined in August by 2.05% after 5 straight months of gains. We continue to produce strong performance